NCT02742441View on ClinicalTrials.gov

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)

PHASE3CompletedINTERVENTIONAL
Enrollment

409

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

February 27, 2017

Study Completion Date

June 16, 2017

Conditions
Plaque Psoriasis
Interventions
DRUG

122-0551 Foam

Topical Foam containing active drug

DRUG

Vehicle Foam

Topical Foam containing no active drug

Trial Locations (21)

23507

Site 21, Norfolk

28405

Site 08, Wilmington

33014

Site 20, Miami Lakes

33162

Site 11, North Miami Beach

33511

Site 16, Brandon

33756

Site 15, Clearwater

33781

Site 12, Pinellas Park

37215

Site 05, Nashville

43230

Site 04, Gahanna

46032

Site 10, Carmel

47150

Site 06, New Albany

48103

Site 07, Ann Arbor

64506

Site 02, Saint Joseph

71913

Site 01, Hot Springs

72916

Site 14, Fort Smith

78229

Site 18, San Antonio

78746

Site 09, Austin

80220

Site 19, Denver

91436

Site 17, Encino

99202

Site 03, Spokane

02169

Site 13, Quincy

All Listed Sponsors
lead

Therapeutics, Inc.

INDUSTRY

NCT02742441 - A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310) | Biotech Hunter | Biotech Hunter